国家: 澳大利亚
语言: 英文
来源: Department of Health (Therapeutic Goods Administration)
calcium folinate, Quantity: 10.8 mg/mL (Equivalent: calcium folinate, Qty 10 mg/mL; Equivalent: folinic acid, Qty 10 mg/mL)
Hospira Australia Pty Ltd
Calcium folinate
Injection
Excipient Ingredients: hydrochloric acid; water for injections; sodium chloride; sodium hydroxide
Intramuscular, Intravenous Infusion
1 x 5 mL vial
Medicine Listed (Export Only)
(S1) This Schedule is intentionally blank
Calcium Leucovorin is indicated in:a) Neutralising the immediate toxic effects of folic acid antagonists, e.g. Methotrexate b) Calcium Leucovorin Rescue - a treatment technique using Calcium Leucovorin in conjunction with folic acid antagonists, e.g. Methotrexate, to minimise systemic toxicity. c) The treatment of megaloblastic anaemias due to sprue, nutritional deficiency, pregnancy, infancy, liver disease and malabsorption syndrome.
Visual Identification: A clear, straw to pale yellow coloured solution, free from particulate matter; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 2 Years; Container Temperature: Store at 2 to 8 degrees Celsius; Container Closure: Child resistant closure and restricted flow insert
Listed (Export Only)
2007-06-13